GeoPharma does deal with Schering over Clarinex

Reuters notes: Under the settlement, GeoPharma can commercially launch its generic product, with 6 months marketing co-exclusivity, on July 1, 2012, or earlier in certain circumstances.

See also
http://ipbiz.blogspot.com/2008/12/dr-reddys-settles-with-schering-over.html [Under the settlement, India-based Dr. Reddy's will be able to sell generic versions Clarinex-D 12 Hour, Clarinex-D 24 Hour, and Clarinex Reditabs starting in 2012.]